EEOS reduced vascular endothelial growth factor production and MMP-9 activity in metastatic-induced NCI-H460 non-small cell lung cancer cells by inhibiting the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway (Kwak et al., 2014). This evidence concerns the gene MMP9 and non-small cell lung carcinoma.